Brief: Willow Announces Collaboration With Biopharmaceutical Company To Develop Sustainable Intermediates And Active Pharmaceutical Ingredients
21/08/2023 12:13
Aug 21 (Reuters) - Willow Biosciences Inc WLLW.TO :
* WILLOW ANNOUNCES COLLABORATION WITH A LEADING INNOVATIVE
BIOPHARMACEUTICAL COMPANY TO DEVELOP SUSTAINABLE INTERMEDIATES
AND ACTIVE PHARMACEUTICAL INGREDIENTS
Source text for Eikon: ID:nCNWl0Kn6a
Further company coverage: WLLW.TO
(Reuters.Briefs@thomsonreuters.com)
Recent news on Atlas Energy
See all newsBrief: Atlas Energy Corp. Announces Appointments To Subsidiary Board And Extension Of Tsxv Sandbox Exit Deadline
Brief: Atlas Energy Reports Second Quarter 2025 Financial Results
Brief: Atlas Energy Reports Second Quarter 2025 Financial Results
Brief: Atlas Energy Strengthens Leadership Team With Appointment Of Andy Duncan As Senior Executive
Brief: Willow Biosciences Announces Completion Of Transformative Recapitalization Transactions To Form Atlas Energy Corp